In heart transplant recipients, PCSK9 inhibitors lowered LDL, stabilized coronary intimal hyperplasia and were associated with minimal adverse effects, according to data from the virtual Heart Failure Society of America Scientific Meeting.

Yasser Sammour, MD, internal medicine resident at Saint Luke’s Mid-America Heart Institute, and colleagues analyzed 68 patients from Saint Luke’s who received a heart transplant from 1999 to 2019 and were prescribed a PCSK9 inhibitor after the transplant.

Read the full article about the findings: Healio: PCSK9 inhibitors safe, effective in patients with heart transplants

Read more >

Related Content

  • Person, Hair, Nurse, Face, Female, Word
    Nicole's story

    "What we do is so vital. We have so much power as nurses." Nicole Roberson, Registered Nurse, Neuroscience ICU, Saint Luke's Hospital of Kansas City

    Read more >
  • Person, Doctor, Clothing, Apparel, Lab Coat, Coat, Face, Nurse
    Deb's story

    Deb Day, Registered Nurse · Anderson County Hospital "I am a Saint Luke's Nurse.  Nurses are the lifeblood of Saint Luke’s compassionate care, and the life-changing work they do is...

    Read more >
  • Apparel, Clothing, Coat, Lab Coat, Person, Doctor
    Danielle's story

    "You get those rare moments that you're reminded why you went into this field, and it makes everything so much better." Danielle Hammontree, Certified Family Nurse Practitioner, Saint Luke’s East Hospital

    Read more >